Your browser doesn't support javascript.
loading
An Update on the Application of CRISPR Technology in Clinical Practice.
Morshedzadeh, Firouzeh; Ghanei, Mahmoud; Lotfi, Malihe; Ghasemi, Morteza; Ahmadi, Mohsen; Najari-Hanjani, Parisa; Sharif, Samaneh; Mozaffari-Jovin, Sina; Peymani, Maryam; Abbaszadegan, Mohammad Reza.
Afiliação
  • Morshedzadeh F; Department of Genetics, Faculty of Basic Sciences, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.
  • Ghanei M; Department of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Lotfi M; Department of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Ghasemi M; Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Ahmadi M; Department of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Najari-Hanjani P; Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Sharif S; Cellular and Molecular Research Center, Qom University of Medical Sciences, Qom, Iran.
  • Mozaffari-Jovin S; Department of Medical Genetics, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran.
  • Peymani M; Department of Medical Genetics, Faculty of Advanced Technologies in Medicine, Golestan University of Medical Science, Gorgan, Iran.
  • Abbaszadegan MR; Department of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mol Biotechnol ; 66(2): 179-197, 2024 Feb.
Article em En | MEDLINE | ID: mdl-37269466
ABSTRACT
The CRISPR/Cas system, an innovative gene-editing tool, is emerging as a promising technique for genome modifications. This straightforward technique was created based on the prokaryotic adaptive immune defense mechanism and employed in the studies on human diseases that proved enormous therapeutic potential. A genetically unique patient mutation in the process of gene therapy can be corrected by the CRISPR method to treat diseases that traditional methods were unable to cure. However, introduction of CRISPR/Cas9 into the clinic will be challenging because we still need to improve the technology's effectiveness, precision, and applications. In this review, we first describe the function and applications of the CRISPR-Cas9 system. We next delineate how this technology could be utilized for gene therapy of various human disorders, including cancer and infectious diseases and highlight the promising examples in the field. Finally, we document current challenges and the potential solutions to overcome these obstacles for the effective use of CRISPR-Cas9 in clinical practice.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistemas CRISPR-Cas / Edição de Genes Limite: Humans Idioma: En Revista: Mol Biotechnol Assunto da revista: BIOLOGIA MOLECULAR / BIOTECNOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistemas CRISPR-Cas / Edição de Genes Limite: Humans Idioma: En Revista: Mol Biotechnol Assunto da revista: BIOLOGIA MOLECULAR / BIOTECNOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Irã